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ABSTRACT
Endogenous 5-methylcytosine (MeC) residues are
found at all CG dinucleotides of the p53 tumor sup-
pressor gene, including the mutational ‘hotspots’ for
smoking induced lung cancer. MeC enhances the
reactivity of its base paired guanine towards car-
cinogenic diolepoxide metabolites of polycyclic
aromatic hydrocarbons (PAH) present in cigarette
smoke. In the present study, the structural basis
for these effects was investigated using a series of
unnatural nucleoside analogs and a representative
PAH diolepoxide, benzo[a]pyrene diolepoxide
(BPDE). Synthetic DNA duplexes derived from a fre-
quently mutated region of the p53 gene (50-CCCGGC
ACCC GC[15N3,
13C1-G]TCCGCG-3
0, + strand) were
prepared containing [15N3,
13C1]-guanine opposite
unsubstituted cytosine, MeC, abasic site, or unnat-
ural nucleobase analogs. Following BPDE treat-
ment and hydrolysis of the modified DNA to
20-deoxynucleosides, N2-BPDE-dG adducts formed
at the [15N3,
13C1]-labeled guanine and elsewhere
in the sequence were quantified by mass spectrom-
etry. We found that C-5 alkylcytosines and related
structural analogs specifically enhance the reactiv-
ity of the base paired guanine towards BPDE and
modify the diastereomeric composition of N2-
BPDE-dG adducts. Fluorescence and molecular
docking studies revealed that 5-alkylcytosines and
unnatural nucleobase analogs with extended
aromatic systems facilitate the formation of
intercalative BPDE–DNA complexes, placing BPDE
in a favorable orientation for nucleophilic attack by
the N2 position of guanine.
INTRODUCTION
Benzo[a]pyrene (B[a]P, Scheme 1) is the best known rep-
resentative of polycyclic aromatic hydrocarbons (PAH)
produced from incomplete combustion of organic
material. B[a]P and other PAHs are ubiquitously present
in cigarette smoke, urban air and cooked food. Studies in
animal models have shown that B[a]P is a potent systemic
and local carcinogen that induces skin, stomach and lung
tumors, and is considered a likely causative agent for
smoking-induced cancer (1,2). Metabolic activation of
B[a]P by cytochrome P450 monooxygenases produces
DNA-reactive ‘bay region’ diol epoxides, e.g. (+)-anti-
benzo[a]pyrene-r-7,t-8-dihydrodiol-t-9,10-epoxide [(+)-
anti-BPDE] and ()-anti-benzo[a]pyrene-s-7,t-8-
dihydrodiol-t-9,10-epoxide [()-anti-BPDE] (Scheme 1)
which are considered the ultimate carcinogenic species of
B[a]P (3–5).
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Spectroscopic studies have shown that BPDE forms
physical complexes with DNA, which precede their
chemical reactions with DNA. Both major groove
binding and intercalative BPDE-DNA binding motifs
have been identiﬁed (6). In the intercalative complex, the
pyrene ring system of BPDE is ‘sandwiched’ between two
adjacent base pairs of DNA, leading to a red shift of the
ﬂuorescence maximum of BPDE from 343 to 353–354 nm
(7). Importantly, intercalative BPDE–DNA complexes
facilitate the nucleophilic attack by the exocyclic amino
group of guanine at the C-10 epoxide position of BPDE
and catalyze the 9,10-epoxide ring opening (8,9). Trans
addition of guanine to the C-10 position of (+) and ()-
anti-BPDE produces (+)-trans-N2-BPDE-dG and ()-
trans-N2-BPDE-dG, while cis addition results in (+) and
()-cis-N2-BPDE-dG isomers (Scheme 1). While trans-N2-
BPDE-dG adducts are the most common diastereomers
in vivo (10), the cis adducts are preferentially generated
under high salt conditions (11,12). Cis and trans N2-
BPDE-dG have distinct conformations in DNA, which
inﬂuences their recognition by DNA repair proteins
(13,14). The BPDE moiety of the trans adducts is typically
found in an external minor groove conformation, with
B-DNA helix undergoing minimal distortion (15,16). In
contrast, the cis adducts assume intercalative conform-
ation by displacing the modiﬁed guanine residue and its
partner cytosine into the major groove [the ()-cis isomer]
or into the minor groove of DNA [(+)-cis] (17). Adduct
conformations can be further inﬂuenced by DNA super-
coiling and by the local sequence context (18,19).
5-Methylcytosine (MeC) is an important endogenous
DNA modiﬁcation that plays a central role in epigenetic
regulation, chromatin structure and DNA repair (20). The
majority of MeC residues are found at 50-CG-30 dinucleo-
tides, including all 50-CG-30 sites within the coding
sequence of the human p53 tumor suppressor gene (21).
Interestingly, BPDE and other diol epoxides produced
upon bioactivation of PAHs present in tobacco smoke
exhibit an enhanced reactivity towards the N2-position
of guanine in MeC:G base pairs (22–25). In particular,
N2-BPDE-dG adducts are preferentially formed at
guanine bases within MeCG dinucleotides found at the
major mutational ‘hotspots’ characteristic for smoking-
induced lung cancer, e.g. codons 157, 158, 245, 248 and
273 of the p53 tumor suppressor gene (22–25). Our studies
with partially methylated CG dinucleotides revealed
that this reactivity enhancement can be attributed to
MeC that is base paired with target guanine, rather
than the methylated cytosine present in the 50-ﬂanking
position (22).
The origins of 5-methylcytosine mediated effects on N2-
BPDE-dG adduct formation are not well understood.
Previous experimental and computational studies with
mitomycin C, an antitumor agent that forms precovalent
intercalative complexes with DNA, suggest that the
nucleophilicity of the N2-position of guanine is enhanced
as a result of the inductive electronic effects of the C-5
methyl group transmitted to the N2-amino group of G
through MeC:G hydrogen bonds (26). Consistent with
this explanation, the presence of electron withdrawing
Scheme 1. Metabolic activation of benzo[a]pyrene to BPDE and the formation of guanine adducts.
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ﬂuoro group on the C-5 of cytosine reduces the reactivity
of G:C base pairs towards mitomycin C (26,27). These
studies suggest that the transmitted electronic effect of
the methyl group may be an important factor in
determining reactivity of alkylating agents, such as
BPDE, towards the N2-position of guanine. However,
our experiments with non-intercalating DNA alkylating
agents have shown that cytosine methylation decreases
the yields of O6-alkyldeoxyguanosine adducts induced by
alkyldiazonium ions (28,29) and does not affect the for-
mation of N2-ethyl-deoxyguanosine adducts of acetalde-
hyde (30). Therefore, C-5 cytosine methylation may
enhance the reactivity of PAH diolepoxides towards CG
dinucleotides by a mechanism that is distinct from its
effects on electron density distribution.
Although cytosine methylation does not interfere with
the overall DNA structure (the C-5 methyl substituent is
readily accommodated in the major groove of DNA)
(31–33), MeC decreases the major groove charge density,
stabilizes DNA helix and enhances base stacking (32,34).
The introduction of a hydrophobic methyl group at the
C-5 position of cytosine may encourage the physical
binding of BPDE to DNA grooves. Furthermore, since
C-5 methylation increases the molecular polarizability of
cytosine (32,35), it is likely to stabilize intercalative
complexes of aromatic carcinogens such as BPDE with
DNA via increased p–p stacking interactions (36).
Indeed, Geacintov et al. (8) have shown that MeC
enhances the intercalative binding of BPDE to
poly(dG-MeC) duplexes and shifts the orientation of ()-
trans N2-BPDE-dG adducts from an external minor
groove structure to an intercalative conformation
(37,38). The preferential precovalent complex formation
at MeC:G base pairs is expected to increase the yields of
N2-BPDE-dG adducts at methylated CG dinucleotides.
The purpose of this work was to identify the mechan-
ism(s) by which the presence of the C-5 methyl group on
cytosine alters the reactivity of endogenously occurring
50-MeCG-30 steps in DNA towards BPDE and other
PAH diolepoxides. A series of C-5 substituted cytosines
and related structural analogs, including 5-ethyl-C,
5-propyl-C, N4-ethyl-C, 5-ﬂuoro-C, 5-chloro-C (39),
5-bromo-C, 5-iodo-C, diﬂuorotoluene (40), 5-propynyl-
C, pyrrolo-C, 6-phenylpyrrolo-C (41) and perimidin-2-one
nucleoside (dPER) (42) (Scheme 2), were placed into syn-
thetic DNA duplexes opposite [15N3,
13C1]-guanine and
Scheme 2. Nucleoside analogs employed in the present study.
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the formation of N2-guanine adducts at the modiﬁed C:G
base pairs was quantiﬁed by stable isotope labeling mass
spectrometry. The pre-covalent BPDE:DNA interactions
were evaluated by low temperature laser-excited ﬂuores-
cence spectroscopy, quantum mechanical calculations and
molecular docking experiments. Our results demonstrate
that the presence of C-5 alkylcytosines and base ana-
logs with extended aromatic systems facilitates the forma-
tion of intercalative BPDE-DNA complexes and
increases the rates of N2-BPDE-dG adduct formation at
structurally modiﬁed G:C base pairs. Similar results
were observed for other PAH diolepoxides, e.g.
benzo[c]phenanthrene-3,4-diol-1,2-epoxide (B[c]PhDE),
benzo[g]chrysene-11,12-diol-13,14-epoxide (B[g]CDE),
dibenzo[a,l]pyrene-11,12-diol 13,14-epoxide (dB[a,l]PDE)
and 5-methyl chrysene-1,2-diol-3,4-epoxide (5-MeCDE)
(Supplementary Figure S1). Taken together, these
ﬁndings offer a likely explanation for the increased re-
activity of PAH diolepoxides and other DNA
intercalating agents towards endogenously methylated
G:C sites.
MATERIALS AND METHODS
Caution
Benzo[a]pyrene diol epoxide (BPDE), benzo[c]phe-
nanthrene-3,4-diol 1,2-epoxide (B[c]PhDE), benzo[g]
chrysene-11,12-diol 13,14-epoxide (B[g]CDE),
dibenzo[a,l]pyrene-11,12-diol 13,14-epoxide (dB[a,l]PDE)
and 5-methyl chrysene1,2-diol 3,4-epoxide (5-MeCDE)
are carcinogenic and should be handled with extreme
caution.
Materials
(±)-Anti-BPDE, ()-anti-BPDE, benzo[a]pyrene-7S-
trans-7,8-dihydrodiol [(+)-BP78D] and benzo[a]pyrene-
r-7,t-8,9,10-tetrahydrotetraol (trans-anti BPT or BPT)
were obtained from the NCI Chemical Carcinogen
Repository (Midwest Research Institute, Kansas City,
MO, USA). B[c]PhDE, B[g]CDE, dB[a,l]PDE and
5-MeCDE were synthesized as described in the literature
(43–46). DNase I, PDE I and PDE II were bought from
Worthington Biochemical Corporation (Lakewood, NJ,
USA). Alkaline phosphatase and DOWEX 50WX8-200
beads were purchased from Sigma-Aldrich (St Louis,
MO, USA). Solid phase extraction (SPE) C18 SPE cart-
ridges (50mg) were obtained from Water Associates.
Micro BioSpin 6 columns were purchased from Bio-Rad
(Hercules, CA, USA) and illustra
TM
NAP-5 Columns were
obtained from GE Healthcare (Piscataway, NJ, USA). All
HPLC and liquid chromatography/mass spectrometry
(LC/MS) grade solvents were purchased from Fisher
Scientiﬁc (Fair Lawn, NJ, USA).
Synthesis of DNA strands containing unnatural base
analogs
Synthetic oligodeoxynucleotides representing codons 153–
158 of the human p53 tumor suppressor gene (50-CCCGG
CACCCGC [15N3,
13C1-G]TCCGCG-3
0) were prepared
by solid phase synthesis on an ABI 394 DNA
Synthesizer (Applied Biosystems, CA, USA) (47).
Structurally modiﬁed C:G base pairs were incorporated
at the ﬁrst position of p53 codon 157, which is a prominent
mutational ‘hotspot’ in smoking induced lung cancer (48).
Nucleoside phosphoramidites (PA) of 5-ﬂuoro-C,
5-bromo-C, 5-iodo-C, diﬂuorotoluene, 5-propynyl-C,
protected abasic site and pyrrolo-C were purchased
from Glen Research Corporation (Sterling, VA,
USA). 1,7,NH2-
15N3-2-
13C1-dG-phosphoramidite and
perimidin-2-one nucleoside (dPER) phosphoramidite
were prepared as reported previously (42,49,50). O4-
ethyl-5-chloro-20-deoxyuridine phosphoramidite was
synthesized and incorporated into the oligodeoxy-
nucleotide following the methods of Kang et al. (39).
5-Ethyl-20-deoxycytidine and 5-propyl-20-deoxycytidine
were prepared from 5-iodo-20-deoxycytidine by the
methods described by Robins et al. (51) and converted
to the corresponding PA derivatives by standard
phosphoramidite chemistry (47). 6-Phenylpyrrolo-dC
phosphoramidite was prepared as described previously
(52). Manual coupling was employed for the incorpor-
ation of structurally modiﬁed nucleotide units during
solid phase DNA synthesis. Synthetic oligodeoxynu-
cleotides were puriﬁed by reversed phase HPLC as
described elsewhere, (22,28) followed by desalting using
illustra
TM
NAP-5 size exclusion cartridges (GE
Healthcare).
Synthetic oligodeoxynucleotides containing protected
abasic site (1,2,5-O-tris(tert-butyldimethylsilyl)-
3-deoxyhexitol) were synthesized using commercial
phosphoramidite (Glen Research Corporation, Sterling,
VA, USA) and puriﬁed using a Supelcosil LC-18-DB
column (10mm 250mm, 5mm, Supelco, Bellefonte,
PA, USA) eluted at 40C and a ﬂow rate of 3ml/min.
HPLC buffers were 100mM triethylammonium acetate,
pH 7.0 (A) and acetonitrile (B). A linear gradient of
15–50% B in 35min was employed, followed by isocratic
elution at 50% B for an additional 5min. The
tert-butyldimethylsilyl protecting groups were removed
by incubation in 40% acetic acid for 4 h at room tem-
perature, and the deprotected oligodeoxynucleotide con-
taining 1,2,5-trihydroxy-3-deoxyhexitol was puriﬁed on a
Supelcosil LC-18-DB column (10mm 250mm, 5mm)
maintained at 40C. The 1,2,5-trihydroxy-3-deoxyhexitol
moiety was converted to an abasic site by incubation in
100mM sodium acetate buffer, pH 6.0, containing 5mM
sodium periodate for 5min at room temperature.
Following desalting, DNA strands containing structur-
ally modiﬁed bases were characterized by HPLC-ESIMS
(Supplementary Table S1) (22), UV melting
(Supplementary Table S2) and exonuclease ladder
sequencing (Supplementary Tables S3 and S4) (53). To
obtain double-stranded DNA, equimolar amounts of
the complementary strands (200 mM) were combined in
10mM Tris–HCl buffer, pH 8.0, containing 50mM
NaCl, followed by heating to 90C and slowly cooling to
room temperature. CD spectra and UV melting tempera-
tures of each structurally modiﬁed duplex were obtained
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as described in the Supplementary Data and are shown in
Supplementary Figures S2 and S3, respectively.
DNA treatment with PAH diolepoxides and analysis of
N2-PAH-dG adducts
Double-stranded DNA 19-mers containing centrally pos-
itioned X:[15N3,
13C1-dG] base pairs, where X=cytosine,
5-methylcytosine or unnatural nucleobase analog
(Supplementary Table S2, Scheme 2), were dissolved in
50mM Tris–HCl buffer, pH 7.5, to reach a concentration
of 40 mM (22). Stock solutions of (±)-anti-BPDE, ()-
anti-BPDE, B[c]PhDE, B[g]CDE, dB[a,l]PDE and
5-MeCDE were prepared in dry DMSO, and their concen-
trations were determined by UV spectrophotometery
(BPDE: e345=48 800M
1 cm1; B[c]PhDE: e266=
32 106M1 cm1, B[g]CDE: e269=10 881M
1 cm1,
dB[a,l]PDE: e299=21 717M
1 cm1, 5-MeCDE:
e266=6580M
1 cm1). An appropriate amount of each
PAH diolepoxide was added to the DNA solution to
achieve 8 mM concentration, with DMSO making up
10% of the volume. Following 18 h incubation on ice,
the reaction mixtures were dried under reduced pressure
and re-dissolved in 10mM Tris–HCl/15mM MgCl2
buffer, pH 7. Enzymatic digestion of DNA to
20-deoxyribonucleosides was achieved by incubation with
DNAse I (105 U), PDE I (105 mU), PDE II (108 mU) and
alkaline phosphatase (22 U), for 18 h at 37C. To conﬁrm
that the enzymatic digestion was complete, a small aliquot
of each digest was removed and analyzed by HPLC-UV
(22). The resulting PAH diolepoxide–deoxyguanosine
adducts were isolated by SPE on C18 SPE cartridges
(50mg, from Water Associates) as described previously
(25). SPE fractions containing modiﬁed nucleosides were
concentrated under vacuum and analyzed by HPLC-
ESI-MS/MS.
HPLC-ESI-MS/MS analysis
Capillary HPLC-ESI+-MS/MS analyses were performed
with an Agilent 1100 capillary HPLC system interfaced
to a Finnigan Quantum Discovery triple quadrupole
(TSQ) mass spectrometer. Chromatographic separation
of N2-BPDE-dG diastereomers was achieved with a
Waters 3 mm Atlantis C18 column (300mm 150mm)
maintained at 15C and eluted at a ﬂow rate of 3.5ml/
min. The HPLC solvents were 15mM ammonium
acetate (A) and methanol (B), with a linear gradient of
47–50% B in 30min, followed by isocratic elution at
50% B for 20min. N2-BPDE-dG stereoisomers eluted as
follows: ()-trans-N2-BPDE-dG (tR, 43.0min), (+)-cis-N2-
BPDE-dG (tR, 45.5min), ()-cis-N2-BPDE-dG (tR,
49.2min) and (+)-trans-N2-BPDE-dG (tR, 51.3min). The
mass spectrometer was operated in the ESI+ mode.
Selected reaction monitoring (SRM) analysis was per-
formed by following the transitions corresponding to a
loss of deoxyribose from protonated molecules of the
adducts: m/z 570.1!454.1 (N2-BPDE-dG) and m/z
574.1!459.1 (15N3, 13C1-N2-BPDE-dG) (22). Isotopic
labeling experiments involving N2-B[c]PhDE-dG, N2-
B[g]CDE-dG, N2-dB[a,l]PDE and N2-5-MeCDE-dG
were conducted analogously as described in
Supplementary Data.
The extent of N2-BPDE-dG formation at the 15N3,
13C1-dG was calculated according to the equation:
Percentage reaction at X ¼ A15N,13CBPDEdGðA15N,13CBPDEdG+ABPDEdGÞ
,
where ABPDE-dG and A15N,13C-BPDE-dG are the areas
under the HPLC-ESI-MS/MS peaks corresponding to
the unlabeled and [15N, 13C]-labeled N2-BPDE-dG,
respectively.
Results were expressed as a ratio of relative reactivity
of 15N3,
13C1-G when paired with speciﬁc base analog
versus the reactivity of the standard G: C base pair.
Relative contributions of N2-BPDE-dG isomers to the
total adduct number were expressed as percentages in
pie chart format. Statistical analyses of the data were con-
ducted as described in the Supplementary Data.
Chromatographic separation of ()-trans-N2-
BPDE-dG and ()-cis-N2-BPDE-dG adducts resulting
from DNA treatment with ()-anti-BPDE was achieved
with a YMC ODS-AQ column (320 mm  100mm, 5 mm).
The column was maintained at 30C and eluted at a ﬂow
rate of 8 ml/min isocratically with 5mM ammonium
acetate containing 0.02% formic acid and 44.5% B
methanol. Under these conditions, the retention times
of ()-trans-N2-BPDE-dG and ()-cis-N2-BPDE-dG
were 10.0 and 11.5min, respectively (Supplementary
Figure S4). The mass spectrometer was operated in the
ESI+-MS/MS mode, and the quantitative analysis of N2-
BPDE-dG was performed as described above.
Kinetic analysis of N2-BPDE-dG adduct formation in
G:C and G:MeC base pairs
Double-stranded DNA 19-mers containing centrally pos-
itioned X:[15N3,
13C1-dG] base pairs (5
0-CCCGGCACCC
GC[15N3,
13C1-G]TCCGCG-3
0, + strand; GGG CCG
TGG GCG XAG GCG C, – strand, where X=cytosine
or MeC; 25–1000 pmol), were dissolved in 50mM Tris–
HCl buffer (45 ml, pH 7.5). (±)-Anti-BPDE (400 pmol, in
5 ml of DMSO) was added to the DNA sample, followed
by rapid mixing by vortex. Following 1min incubation,
the reactions were quenched with the addition of
2-mercaptoethanol (20 nmol). Samples were spiked with
B[g]CDE-dG (2.7 pmol, internal standard for mass spec-
trometry), dried under reduced pressure, and re-dissolved
in 10mM Tris–HCl/15mM MgCl2 buffer, pH 7.
Enzymatic digestion of DNA to 20-deoxyribonucleosides
and SPE of N2-BPDE-dG and [15N3,
13C1]-N
2-BPDE-dG]
adducts were conducted as described previously (25). SPE
fractions containing N2-BPDE-dG were concentrated
under vacuum and analyzed by HPLC-ESI+-MS/MS as
described above. N2-BPDE-dG and [15N3,
13C1]-N
2-
BPDE-dG] were quantiﬁed from the corresponding
HPLC-ESI+-MS/MS peak areas using calibration curves
constructed by analyzing solutions containing known
amounts of B[g]CDE-dG, N2-BPDE-dG and [15N3,
13C1]-
N2-BPDE-dG.
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Low-temperature ﬂuorescence spectroscopy
Fluorescence spectra of benzo[a]pyrene-r-7,t-8,9,10-
tetrahydrotetraol (trans-anti BPT or BPT) and its
complexes with DNA were recorded at 77K using excita-
tion wavelengths of 346 or 355 nm (54). Double-stranded
DNA 19-mers containing a centrally positioned X:G base
pair (50-CCCGGCACCC GCGTCCGCG-30, + strand;
GGG CCG TGG GCG XAG GCG C, – strand, where
X=cytosine, 5-methylcytosine, or dPER) were dissolved
in 50mM Tris–HCl buffer, pH 7.5, to reach a concentra-
tion of 40 mM. Stock solutions of BPT were prepared in
DMSO and its concentrations were determined by UV
spectrophotometry (e345=48 800M
1 cm1). An appro-
priate aliquot of the BPT solution was added to the
DNA solution to achieve 8 mM concentration of BPT,
with DMSO making up 10% of the volume. Control
samples in the absence of DNA contained 8 mM BPT
dissolved in 50mM Tris–HCl, pH 7.5 buffer, with
DMSO making up 10% of the volume. For all ﬂuores-
cence measurements, samples were placed into quartz
tubes and immediately (within 5–8 s) immersed in a
liquid nitrogen cryostat with quartz optical windows.
Fluorescence spectra were taken at 77K using laser exci-
tation at 346 and 355 nm excitation wavelenghts provided
by the excimer pumped dye laser (i.e. a Lambda Physik
FL 2002). Scanmate tunable dye laser system was
operated at the frequency of 10Hz. A 1m McPherson
monochromator (model 2601) and a Princeton
Instruments photodiode array were used for the dispersion
and the detection of ﬂuorescence. A Princeton
Instruments FG-100 pulse generator was used for
time-resolved spectroscopy with detector delay times
from 60 to 100 ns and a gate width of 200 ns.
Acquisition time (60 s) was applied to all spectra. The
resolution for the ﬂuorescence spectra was ±0.4 nm.
Computational studies
All density functional calculations were performed in
accord with the standardized protocol used to construct
the QCRNA database, a recently developed online
database of quantum calculations for RNA catalysis
(http://theory.chem.umn.edu/Database/QCRNA) (55).
All structures were optimized in the gas phase with
B3LYP/6-31++G** as implemented in the Gaussian03
suite of programs and described by Giese et al. (55). The
molecular structure of ()-anti BPDE was built in
Gaussian03 (Gaussian 03 revision E.01, Gaussian, Inc.,
Wallingford, CT, USA) using B3LPY and HF/6-31G
(55). The intercalation sites (within GC/CG and AT/CG
stacks) were obtained from the PDB data bank with
the PDB ID 151D (56) and 1CXO (57), respectively. The
structures of the DNA duplexes were obtained by merging
the crystal structure of the intercalation sites with the rest
of the duplex that were assumed to be standard B-DNA
motifs. The duplexes were energy minimized for 20 000
steps, heated to 300K for 40 000 steps, and cooled to
0K for 40 000 steps for three cycles using Molecular
Dynamics with 1 fs integration steps. The intercalation
sites were restrained using a harmonic penalty function.
All calculations were performed using Generalized Born
(GBSA model) (58) model in AMBER 10 software
(AMBER 10, University of California, San Francisco),
using the parm99 force ﬁeld for nucleic acids with the
ff99bsc0 correction (59–61).
The docking calculations were carried out for each of
the BPDE enantiomers in both axial and equatorial con-
formations (Supplementary Figure S6) using a grid
centered at the intercalation site using Lamarckian
Genetic Algorithm (LGA) as implemented in Autodock
4 (62). Molecular Dynamics was performed on the
structures of the complexes for 420 ps using GBSA in
Amber 10. Computational results are summarized in
Supplementary Table S6.
RESULTS
Selection of nucleobase analogs and oligonucleotide
synthesis
In order to investigate the mechanisms by which endogen-
ous MeC increases the efﬁciency of PAH-guanine adduct
formation at the base paired guanine, a series of synthetic
oligodeoxynucleotide duplexes were prepared representing
codons 153–158 of the p53 tumor suppressor gene
(Supplementary Tables S1 and S2). This region of the
p53 gene was selected because it is endogenously
methylated in all human tissues (21), and because en-
dogenously methylated codon 157 is speciﬁcally targeted
for BPDE-dG adduct formation as compared with neigh-
boring guanine bases (24). Furthermore, mutations at
the p53 codon 157 (GTC!TGC) are characteristic
for smoking-induced lung cancer (48). In each duplex,
15N3,
13C1-dG (G) was placed at the ﬁrst position of
p53 codon 157, while cytosine or its structural
analog (X) was introduced in the base paired position.
All synthetic oligodeoxynucleotides were puriﬁed by
HPLC, desalted and characterized by ESIMS
(Supplementary Table S1). Exonuclease ladder sequencing
of the oligodeoxynucleotides using MALDI-TOF MS
conﬁrmed the presence of unnatural nucleobases at
speciﬁed sites within DNA sequence (Supplementary
Tables S3 and S4).
Nucleoside analogs selected for this study span a range
of structures, including C-5 substituted cytosine and
related aromatic and heteroaromatic nucleobase variants
(Scheme 2 above). Analogs with C-5 alkyl substituent on
cytosine [5-methylcytosine (MeC), 5-ethylcytosine (Et-C),
N4-ethylcytosine (N4Et-C) and 5-propylcytosine
(Prop-C)] were chosen to investigate the possibility that
the presence of alkyl groups at the C-5 of cytosine
enhances physical and intercalative binding of BPDE
and other PAH diol epoxides to CG dinucleotides,
thereby increasing the probability of N2-BPDE-dG
adduct formation. In addition, the C-5 alkyl groups on
cytosine can donate electron density to the C:G base
pair, increasing the nucleophilicity of its partner guanine
(26,27).
A series of C-5 halogenated cytosines [5-ﬂuorocytosine
(F-C), 5-chlorocytosine (Cl-C), 5-bromocytosine (Br-C)
Nucleic Acids Research, 2011, Vol. 39, No. 9 3993
and 5-iodocytosine (I-C)] were included to probe the
effects of electron withdrawing groups at the C-5
of cytosine on reactivity of C:G pairs towards BPDE.
The steric impact of these substituents is complementary
to that of s electron-donating alkyl groups. Furthermore,
base analogs with extended aromatic systems
[5-propynylcytosine (Pr-C), 6-methylpyrrolo[2,3-d]
pyrimidine-2(3H)one deoxyribonucleoside (pyrrolo-C),
6-phenylpyrrolo[2,3-d]pyrimidine-2(3H)one deoxyribo-
nucleoside (phenylpyrrolo-C) and perimidin-2-one
deoxyribonucleoside (dPER)] were introduced in order
to enhance the p–p stacking interactions of modiﬁed
base pairs with BPDE. Two additional base analogs,
2,4-diﬂuorotoluene (Dft) (40) and the abasic site, were
included to probe the reactivity of guanine towards
BPDE in the absence of complementary hydrogen
bonding to cytosine.
Effects of nucleobase analogs on DNA duplex structure
and stability
CD spectra of DNA 19-mers containing various
nucleobase mimics (Scheme 2) were similar to the corres-
ponding spectra of duplexes containing unsubstituted dC
and MeC (Supplementary Figure S2), indicating that the
presence these nucleobase modiﬁcations does not alter the
overall DNA structure. Furthermore, UV variable tem-
perature analysis resulted in hyperbolic thermal denatur-
ation curves indicative of the presence of stable B-DNA
duplexes (Supplementary Figure S3). UV melting tem-
peratures of the duplexes containing MeC, Et-C and
Pr-C were slightly higher than for the duplex containing
unsubstituted cytosine (Supplementary Table S2),
although these differences were not statistically signiﬁcant.
This increase is consistent with the known ability of MeC
to enhance base stacking and increase DNA duplex sta-
bility (35,63). Small Tm increases were also observed for
duplexes containing Br-C, Cl-C, I-C and pyrrolo-C
(Supplementary Table S2). In contrast, the thermodynam-
ic stability of DNA containing N4Et-C, Dft, dPER and
the abasic site was decreased relative to the duplexes con-
taining standard G:C base pairs, probably a result of the
disrupted Watson–Crick hydrogen bonding between
guanine and these nucleoside analogs (42,64,65). Indeed,
the introduction of N4-ethyl group is expected to disrupt
the H-bonding interactions between the N4 of ethylated
dC and the O6 of its partner guanine, while no hydrogen
bonding with G is possible for Dft, dPER and the abasic
site (40,42). Only insigniﬁcant changes in Tm were
observed upon the introduction of 5-propyl-C,
5-ﬂuoro-C and 6-phenylpyrrolo-C into DNA duplexes
(Supplementary Table S2).
Stable isotope labeling HPLC-ESI-MS/MS approach
In order to evaluate the effects of nucleobase analogs
on the N2-BPDE-dG adduct formation at the base
paired guanine, isotopically tagged deoxyguanosine
(15N3,
13C1-dG) was placed in DNA duplexes (5
0-CCCG
GCACCCGC [15N3,
13C1-G] TCCGCG-3
0,+strand)
opposite cytosine or a cytosine analog (X) (Scheme 3,
Supplementary Table S2). The resulting structurally
modiﬁed DNA duplexes were treated with (±)-anti-
BPDE or ()-anti-BPDE and enzymatically digested to
20-deoxynucleosides. The resulting diastereoisomeric N2-
BPDE-dG adducts were quantiﬁed by HPLC-ESI+-MS/
MS (Figure 1 and Supplementary Figure S4) (22,25). N2-
BPDE-dG adducts formed at the 15N3,
13C1-labeled
guanine undergo a+4 mass shift and thus can be readily
distinguished from adducts originating from unlabeled
deoxyguanosines elsewhere in the sequence (22,25). The
extent of N2-BPDE-dG formation at the 15N,
13C-labeled guanine was calculated from HPLC-ESI-
MS/MS peak areas as described in the ‘Materials and
Methods’ section. Similar methodology was employed to
quantify the site-speciﬁc formation of N2-guanine adducts
induced by other PAH diolepoxides (Supplementary
Figure S1).
Inﬂuence of C-5 cytosine substituents within CG base
pairs on relative reactivity of (±)-anti-BPDE and
()-anti-BPDE
Normalized yields of N2-BPDE-dG adducts originating
from structurally modiﬁed G:X base pair (where
X=unnatural cytosine analog) in comparison with that
from native G:C pairs are shown as bar graphs in
Figures 2 and 4-6, while the relative contributions of in-
dividual N2-BPDE-dG stereoisomers to the total adduct
number are represented as pie charts in the same ﬁgure.
We found that the yields of BPDE adducts at guanine
placed opposite MeC were 2-fold higher than at
guanines within standard G:C base pairs (Figure 2). This
observation was conﬁrmed by kinetic experiments in
which (±)-anti-BPDE was allowed to react with increasing
amounts of DNA containing a central MeC:G base pair or
unmethylated C:G (Figure 3). N2-BPDE-dG adduct for-
mation at the guanine base paired to MeC was 1.7-2 fold
higher than in the absence of MeC (Figure 3A). In contrast,
MeC had no effect on N2-BPDE-dG adduct formation at
guanine bases elsewhere in the sequence (Figure 3B), sug-
gesting that cytosine methylation speciﬁcally activates its
partner guanine in the opposite strand of DNA towards
carcinogen attack. Similar results were obtained for other
PAH diol epoxides, e.g. (±)-B[c]PhDE, (±)-B[g]CDE,
(±)-dB[a,l]PDE) and (±)-5-MeCDE, with the yields of
N2-guanine adducts 1.2- to 2.8-fold higher at MeC:G
base pairs as compared to unmethylated C:G
(Supplementary Figure S1, Supplementary Table S5). An
even greater reactivity increase (up to 3-fold) was observed
for cytosine analogs containing a larger C-5 alkyl substitu-
ent, e.g. Et-C and propyl-C, while the presence of
N4-ethyl-dC was less activating (Figure 2).
To investigate the effects of electron withdrawing
groups on C-5 of cytosine on reactivity of CG base pairs
towards BPDE, isotopically labeled guanine was placed in
a DNA duplex opposite F-C, Cl-C, Br-C, or I–C
(Figure 4). We found that the presence of halogenated
cytosine either increased or decreased the yields of
BPDE-dG adducts, depending on halogen identity
(Figure 4). A 20–40% decline in reactivity was observed
when guanine was paired with 5-ﬂuoro-dC (F-C) as
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compared with unsubstituted cytosine (P-value=0.0142),
suggesting that the negative inductive effect of the C-5
ﬂuoro group decreases the nucleophilicity of the N2-
position of guanine (26,27). However, guanine-BPDE
adduct formation increased when it was base paired with
Cl-C, Br-C, or I-C (Figure 4), indicating that electronic
factors alone cannot explain the observed reactivity
trends. A similar effect was observed when a structurally
related PAH diolepoxide, B[c]PhDE, was reacted with
DNA duplexes containing MeC, Cl-C, Br-C and I-C
(Supplementary Figure S5).
The most signiﬁcant increase in BPDE adduct forma-
tion (4- to 8-fold) was observed for G:X base pairs
containing nucleobase analogs designed to enhance
carcinogen intercalation into the DNA duplex (Pr-C,
Dft, pyrrolo-C, phenylpyrrolo-C and dPER, Figures 5
and 6). When pyrrolo-C or phenylpyrrolo-C was placed
opposite target guanine in a DNA duplex, the relative re-
activity towards (±)-anti-BPDE was increased by
60–243% as compared to the native G:C base pair
(P 0.0001) (Figure 5). An even greater effect (8-fold
increase) was observed when dPER containing DNA
duplex was treated with ()-anti-BPDE (Figure 6B).
This can be attributed to the increased p– p stacking inter-
actions between BPDE and modiﬁed G:C base pairs con-
taining nucleobase analogs with extended aromatic
systems. Interestingly, a smaller overall effect was
observed for reactions with (±)-anti-BPDE (Figure 6A),
suggesting that dPER speciﬁcally stabilizes the
precovalent complex with the ()-anti diolepoxide. The
introduction of an abasic site opposite the labeled
guanine also increased its reactivity toward (±)-anti-
BPDE (Figure 6). In contrast, the presence of
5-propynyl group on cytosine did not increase
BPDE-dG adduct formation, possibly because of the un-
favorable geometry of the propynyl substituent which
extends far out of the DNA base stack and into the
major groove of DNA (66).
Effects of cytosine analogs on the optical composition of
N2-BPDE-dG adducts
Four diastereoisomers of N2-BPDE-dG: (+)-trans-N2-
BPDE-dG, (+)-cis-N2-BPDE-dG, ()-trans-N2-BPDE-
dG and ()-cis-N2-BPDE-dG, can be formed when
DNA is treated with (±)-anti-BPDE (Scheme 1). Two of
these, ()-trans-N2-BPDE-dG and ()-cis-N2-BPDE-dG,
are formed following treatment with ()-anti-BPDE.
When guanine is base paired with normal cytosine, the
major N2-BPDE-dG adducts generated following treat-
ment with racemic anti-BPDE are (+)-trans-N2-
BPDE-dG (89%), followed by ()-trans-N2-BPDE-dG
(5%), ()-cis-N2-BPDE-dG (4%) and (+)-cis-N2-
BPDE-dG (2%) (pie charts in Figure 2A). A similar
Scheme 3. Experimental scheme for probing the reactivity of structurally modiﬁed C:G base pairs towards BPDE.
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stereoisomer contribution [85–93% (+)-trans-N2-
BPDE-dG, 4–6% ()-trans-N2-BPDE-dG, 2–5% ()-
cis-N2-BPDE-dG and 1–5% (+)-cis-N2-BPDE-dG] is
observed for guanine base paired to MeC, Et-C,
Propyl-C, N4Et-C, Cl-C, Br-C, pyrrolo-C or
phenylpyrrolo-C (see the pie chart graphs in Figures 2A,
4A, 5A and 6A). However, a strikingly different stereo-
speciﬁcity was observed when the target guanine was
placed opposite Dft, dPER or the abasic site
(Figure 6A). For the guanine:Dft pairs, (+)-trans-N2-
BPDE-dG and (+)-cis-N2-BPDE-dG adducts were
formed in equal amounts (33–39% each), while the
minor isomers were ()-trans-N2-BPDE-dG and ()-
cis-N2-BPDE-dG (12–18% each). (+)-Trans-N2-
BPDE-dG and ()-trans-N2-BPDE-dG were the most
abundant isomers formed at the G: dPER base pairs
(Figure 6). As discussed above, the presence of dPER
appears to increase the reactivity of modiﬁed DNA
duplexes towards ()-anti-BPDE. When target guanine
was placed opposite an abasic site, (+)-cis-N2-BPDE-dG
became the major adduct (46%), followed by (+)-
trans-N2-BPDE-dG (25%), ()-cis-N2-BPDE-dG (18%)
and ()-trans-N2-BPDE-dG (11%, see the pie charts in
Figure 6A). These differences are not due to salt effects,
since all synthetic oligodeoxynucleotides used in these ex-
periments were desalted and annealed under carefully
controlled conditions.
A smaller, but still signiﬁcant, shift in stereochemistry
was observed when the same duplexes were treated with
optically pure ()-anti-BPDE (pie charts in Figures 2B,
4B, 5B and 6B). While ()-trans-N2-BPDE-dG was the
major diastereomer produced at the guanine bases
paired to C, MeC, Et-C, propyl-C, N4Et-C, Cl-C, Br-C,
Dft, pyrrolo-dC, phenylpyrrolo-C and dPER (55–75%),
()-cis-N2-BPDE-dG became the main adduct when
15N3,
13C1-labeled guanine was placed opposite F-C,
I-C, Pr-C, or the abasic site (pie charts in Figures 4B
and 6B). Taken together, our results indicate that the
presence of unnatural cytosine analogs strongly inﬂuences
the stereoisomeric composition of N2-BPDE-dG adducts
produced at the base paired guanine, probably by
changing BPDE conformation in the precovalent
BPDE:DNA complexes.
Spectroscopic studies of trans-anti-BPT complexed
with DNA
Fluorescent spectra of molecules with pyrene moiety are
known to be sensitive to solvent effect (67,68).
Low-temperature ﬂuorescence spectroscopy is frequently
used to probe interactions between these chromophores
and their environments through spectral shifts and
relative peak intensity changes. This technique has been
previously applied to study the conformation of
BPDE-DNA adducts in DNA and physical complexes of
benzo[a]pyrene tetrols with anti-PAH monoclonal
antibody (69). In the present study, ﬂuorescence studies
were conducted in order to evaluate the pre-covalent inter-
actions between ()-anti-BPDE and DNA duplexes con-
taining standard and structurally modiﬁed base pairs.
Since the diolepoxide is hydrolytically unstable in the
presence of DNA (7), trans-anti-BPT was used as a
model compound. This molecule has the same stereochem-
istry at the C-7, C-8, C-9 and C-10 of the hydrocarbon as
(+)-anti-BPDE and retains a similar molecular shape. Our
working hypothesis was that the afﬁnity of BPDE and
BPT towards C:G base pairs in DNA depends on the
identity of the C-5 cytosine substituent.
Figure 7 shows low-temperature ﬂuorescence spectra of
BPT alone and in the presence of DNA duplexes contain-
ing a central G:C, MeC:G or dPER:G base pair. Two laser
wavelengths at 346 and 355 nm were chosen to excite BPT/
DNA physical complexes. These two wavelengths have
been previously shown to be selective for external
(346 nm) and intercalated complexes of PAHs with
DNA (355 nm) (69,70). The origin-band emission spectra
shown in Figure 7A were obtained with an excitation
wavelength ex of 346 nm and 60 ns delay time of the ob-
servation window immediately following mixing of
trans-anti-BPT with DNA. Curves a–c in Figure 7A
were obtained in the presence of DNA duplexes contain-
ing a central C:G, MeC:G or dPER:G base pair, respect-
ively. Spectrum d corresponds to BPT in the absence of
Figure 1. HPLC-ESI-MS/MS analysis of N2-BPDE-dG diastereomers
formed at the 15N3,
13C1-labeled guanine when base paired with
cytosine (A), 5-methylcytosine (B), 5-ﬂuorocyrosine (C) or
perimidin-2-one nucleoside (D) following treatment with (±)-anti-
BPDE. Selected reaction monitoring of 15N5,
13C1-N
2-BPDE-dG was
conducted by following the transitions m/z 574.1 [M+H]+! 459.1
[M+2H-dR]+.
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DNA. Note that the ﬂuorescence spectra of BPT alone
(curve d) and BPT mixed with DNA duplex containing a
central G:C base pair (curve a) are nearly identical, with
the (0,0)-band observed at 376.4 nm (Figure 7A). In
contrast, a 1 nm red shift of the (0,0)-band is observed
when BPT is combined with MeC and dPER containing
duplexes (curves b and c in Figure 7A), suggesting that
BPT has an increased afﬁnity towards DNA containing
modiﬁed base pairs. Identical spectra were obtained for
other delay times of the observation window (data not
shown), suggestive of a deﬁned association between BPT
and structurally modiﬁed DNA duplexes.
Fluorescence spectra a0, b0 and c0 in Figure 7B were
recorded with a different excitation wavelength
(ex=355 nm), which is selective for intercalated con-
formations. As a result, curves a0, b0 and c0 are
characterized by an increased emission at
=380–381 nm (see the dashed arrow and the asterisk
in Figure 7B). Note that the spectra obtained in the
presence of MeC-containing DNA duplex (curve b0) and
dPER-containing DNA (curve c0) are characterized by a
1–1.2 nm red shift of the (0,0)-band (i.e. 377.4 nm in the
MeC analog and 377.6 nm in the dPER analog) and the
band at 380–381 nm, consistent with increased p– p inter-
actions of BPT with structurally modiﬁed duplexes.
Figure 7C shows the difference between emission
spectra obtained at = 346 and 355 nm excitation wave-
lengths. Curves a*, b* and c* correspond to BPTs in the
presence of DNA duplexes containing unmodiﬁed C, MeC
and dPER, respectively. Spectrum a*= a0–a reveals that
the intercalative complex of BPTs with native DNA has
an origin band near 380.1 nm. Curve b*= b0–b reveals a
broader origin band (most likely due to stronger electron–
phonon coupling) that is more red-shifted than a*,
381.1 nm, and shows slightly different frequencies of
the vibronic bands near 388–394 nm. Spectrum c*
obtained for BPT in the presence of dPER-containing
DNA is also red shifted with the (0,0)-band near
Figure 2. Inﬂuence of alkyl substituents on cytosine on the yields of N2-BPDE-dG adducts at the base paired guanine. Synthetic DNA duplexes
derived from p53 exon 5 [50-CCCGGCA CCCGC[15N3,
13C1-G]TCCGCG-3
0, (+) strand] containing cytosine, 5-methylcytosine, 5-ethylcytosine,
5-propylcytosine, or N4-ethylcytosine opposite 15N3,
13C1-G were treated with (±)-anti-BPDE (N=4) (A) or ()-anti-BPDE (N=6) (B) and the
extent of N2-BPDE-dG adduct formation at the isotopically tagged guanine was determined by HPLC-ESI+-MS/MS. Insert: pie charts showing the
relative contributions of ()-trans-N2-BPDE-dG, (+)-cis-N2-BPDE-dG, ()-cis-N2- BPDE-dG and (+)-trans-N2-BPDE-dG to the total adduct
number.
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381.4 nm. This is suggestive of increased p–p interactions
between the pyrenyl residue of BPT and MeC:G or
dPER:G containing DNA as compared to unmethylated
DNA (Figure 7). We conclude that BPT assumes both
quasi-external and intercalated geometries in its complexes
with DNA. Furthermore, a greater contribution of
intercalated structures is observed in the presence of MeC
and dPER as compared to unmodiﬁed duplex. A similar
trend is expected for DNA complexes with BPDE and
other PAH diolepoxides.
Computational analysis of BPDE intercalation into
duplex DNA containing MeC:G base pair
Density functional calculations reveal that BPDE exists in
two low-energy conformations (Supplementary Figure
S6). In conformer I, the 7,8-dihydroxyl groups of BPDE
are in a pseudo-diequatorial orientation, such that the
C-10 position of the 9,10-epoxide is open for the trans
attack by the N2-position of guanine. In conformer II,
the 7,8-hydroxyl groups of BPDE are in a pseudo-diaxial
conformation, making the C-10 position of BPDE more
sterically hindered and less accessible for nucleophilic
attack. Conformer II may instead favor a reaction via
an SN1 mechanism, with an intermediate formation of a
carbocation triol. Our observation of a 20- to 90-fold
excess of (+)-trans N2-BPDE-dG adducts as compared
to (+)-cis products in native DNA (Figure 1, bar graphs
in Figure 2) is consistent with a greater stability of con-
former I of (+)-anti-BPDE as compared to conformer II
(2.5 kcal/mol energy difference based on density function-
al calculations, see panels C and D in Supplementary
Figure S6), favoring the formation of the trans product.
In contrast, the calculated free energies of conformers I
and II of ()-anti-BPDE are nearly equal (panels A and B
in Supplementary Figure S6), consistent with the
Figure 4. Inﬂuence of C-5 halogen substituents on cytosine on the
yields of (±)-anti-BPDE or ()-anti-BPDE-induced N2-BPDE-dG
adducts at the base paired guanine. Synthetic DNA duplexes derived
from p53 exon 5 (50-CCCGGCACCCGC[15N3,
13C1-G]TCCGCG-3
0)
containing cytosine, 5-ﬂuorocytosine, 5-chlorocytosine,
5-bromocytosine, or 5-iodocytosine opposite the target G were
treated with (±)-anti-BPDE (N=4) (A) or ()-anti-BPDE (N=6)
(B) and the extent of N2-BPDE-dG adduct formation at the isotopically
tagged guanine was determined by HPLC-ESI+-MS/MS. Insert: pie
charts showing relative contributions of ()-trans-N2-BPDE-dG, (+)-
cis-N2-BPDE-dG, ()-cis-N2- BPDE-dG and (+)-trans-N2-BPDE-dG
to the total adduct number. *= signiﬁcantly different (P< 0.05).
Figure 3. Effects of cytosine methylation on the kinetics of formation
of N2-BPDE-dG adducts at the base paired guanine (A) and at guanine
bases elsewhere in the sequence (B). Increasing amounts of
double-stranded DNA duplexes derived from p53 exon 5
(50-CCCGGCACCCGC[15N3,
13C1-G]TCCGCG-3
0, (+) strand) con-
taining a single 5-methylcytosine opposite 15N3,
13C1-G were incubated
with (±)-anti-BPDE (N=3) for 1min and quenched with
2-mercaptoethanol. The extent of N2-BPDE-dG adduct formation at
the isotopically tagged guanine (15N3,
13C1-G) and at unlabeled
guanines elsewhere in the sequence was quantiﬁed by HPLC-ESI+-
MS/MS.
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observation of similar amounts of ()-trans and ()-
cis-N2-BPDE-dG adducts upon reactions of ()-anti-
BPDE with DNA (pie chart graphs in Figure 2B).
Our molecular docking experiments were aimed at iden-
tifying the structural factors that control the formation
and the stereochemical identities of N2-BPDE-dG
adducts formed at endogenously methylated C:G base
pairs of DNA. Double-stranded oligonucleotides 50-CCC
GCGTCCGC-30, 30-GGGCGMeCAGGCG-50 were con-
sidered. Open intercalation sites were constructed imme-
diately upstream or downstream from the MeC:G base pair
using intercalated complexes of a similar structure found
in the Protein Databank. A rigid-body docking protocol
was performed, followed by molecular dynamics
simulated annealing that took into account the full ﬂexi-
bility of the BPDE–DNA complex. All possible combin-
ations of anti BPDE stereoisomers [(+) or ()],
diolepoxide conformations (pseudo-diequatorial or
pseudo-diaxial) and transition state geometries (cis or
trans) were considered (Supplementary Table S6).
BPDE–DNA complexes for which the distance between
the exocyclic amino group of G and the C10 of BPDE0s
(d1) was 4.5 A˚ (which are likely to lead to BPDE adduct
formation) were selected for further analysis.
A set of structural indexes was chosen to assess the
interactions between BPDE enantiomers and the MeC:G
site in DNA. First, we considered the formation of
hydrogen bonds between the 7-OH and 8-OH of BPDE
Figure 5. Inﬂuence of cytosine analogs with extended aromatic systems
on the yields of N2-BPDE-dG adducts at the base paired guanine.
Double-stranded DNA duplexes derived from p53 exon 5
(50-CCCGGCACCCGC[15N3,
13C1-G]TCCGCG-3
0) containing
cytosine, 5-propynylcytosine (Pr-C), pyrrolocytosine (pyrrolo-C) or
6-phenylpyrrolocytosine (phenylpyrrolo-C) opposite the target G were
treated with (±)-anti-BPDE (N=4) (A) or ()-anti-BPDE (N=6) (B)
and the extent of N2-BPDE-dG adduct formation at the isotopically
tagged guanine was determined by HPLC-ESI+-MS/MS. Insert: pie
charts showing relative contributions of ()-trans-N2-BPDE-dG, (+)-
cis-N2-BPDE-dG, ()-cis-N2-BPDE-dG and (+)-trans-N2-BPDE-dG
isomers. *= signiﬁcantly different (P< 0.05).
Figure 6. N2-BPDE-dG adduct formation at guanine bases placed in a
DNA duplex opposite unnatural nucleobase analogs unable to form
Watson–Crick hydrogen bonds with G. DNA duplexes derived from
p53 exon 5 (50-CCCGGCACCCGC[15N3,
13C1-G]TCCGCG-3
0) con-
taining cytosine (C), diﬂuorotoluene (Dft), abasic site (abasic), or
perimidin-2-one nucleoside (dPER) opposite the labeled G were
treated with (±)-anti-BPDE (N=4) (A) or ()-anti-BPDE (N=6)
(B), and the extent of N2-BPDE-dG adduct formation at the isotopic-
ally tagged guanine was determined by HPLC-ESI+-MS/MS. Insert: pie
charts showing the relative contributions of ()-trans-N2-BPDE-dG,
(+)-cis-N2-BPDE-dG, ()-cis-N2- BPDE-dG and (+)-trans-N2-
BPDE-dG isomers. *= signiﬁcantly different (P< 0.05).
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and potential hydrogen bond donors/acceptors within the
DNA due to their role in deﬁning product stereochemis-
try. Second, the relative orientations of the 9,10-epoxy
group of BPDE and the N2-guanine in DNA were
evaluated since the epoxide acts as a leaving group in
the nucleophilic substitution reaction leading to
BPDE-dG adduct formation. Finally, we took into
account the distances between the C10 of BPDE and the
exocyclic amino groups of the guanine residues found in
the intercalation site (d1 for the guanine base paired with
MeC and d2 for the 50-ﬂanking guanine), with d1 value
deﬁning the distance between the reactive site of BPDE
and its target guanine (Supplementary Table S6).
The proximity of BPDE to the reactive site within
the MeC:G base pair is dictated by speciﬁc hydrogen
binding patterns between BPDE and DNA. We found
that DNA complexes with the pseudo-diequatorial con-
formers of BPDE (conformer I in Supplementary Figure
S6) are characterized by a closer proximity of the
9,10-epoxide to the exocyclic N2-position of guanine in
DNA and more favorable hydrogen bonding interactions
of BPDE with the neighboring nucleobases and the
phosphodiester backbone of DNA (Supplementary
Table S6).
Our docking experiments suggest a possible explanation
for the enhanced reactivity of BPDE towards methylated
C:G base pairs. In the precovalent BPDE–DNA complex,
the pyrenyl group of BPDE is stacked directly above the
MeC nucleobase, an interaction which is facilitated by the
increased hydrophobic and p–p stacking interactions of
the methylated cytosine with BPDE (Figure 8A). In this
orientation, the epoxide group of BPDE is activated
by hydrogen bonding interactions with the 50-neighboring
G (Figure 8A), facilitating trans epoxide ring opening
by lowering the energy for the transition state for an
SN2-type attack. Examination of molecular models
predicts that the distance between the reactive centers
within guanine and (+)-anti-BPDE (d1) in this complex
is 3.60 A˚ as compared to 3.84 A˚ for ()-anti-BPDE, con-
sistent with the predominance of (+)-trans adducts
observed experimentally (pie charts in Figure 2A).
Alternatively, BPDE can stack with the MeC:G base
pair in an opposite orientation, with the epoxide ring of
BPDE facing the target G and the 7-OH group forming
hydrogen bonds with the neighboring C (Figure 8B). In
this case, the reaction with the target G can only take
place by an SN1-type mechanism, giving rise to cis N
2-
BPDE-dG adducts. The latter reaction is expected to be
slower than the SN2 type substitution due to the require-
ment for carbocation formation and because of a longer
distance between the reactive atoms of BPDE and guanine
in the reactive complex (d1 3.95 A˚ for all arrangements
that yield cis products).
Taken together, our computational results are consist-
ent with the interpretation that the increased reactivity of
BPDE towards endogenously methylated CG dinucleo-
tides is due to the facilitated p–p stacking between
methylated cytosine and the pyrenyl moiety of BPDE.
Furthermore, these molecular models help to explain the
observed stereochemistry of N2-BPDE-dG adducts [(+)-
trans > ()-trans > (+)-cis & ()-cis].
Figure 7. Low temperature (77K) ﬂuorescence origin band spectra of
trans-anti BPT obtained in the absence and in the presence of DNA
duplexes containing a central C:G, MeC:G or dPER:G base pair.
Spectra in (A) were obtained with a ex of 346 nm and a 60 ns delay
time of the observation window immediately after mixing BPT with a
5-fold molar excess of DNA. Curves a–c correspond to the ﬂuorescence
spectra of BPT mixed with DNA duplexes containing C, MeC or dPER,
respectively. Spectrum d corresponds to BPT alone. Spectra in (B) were
obtained with ex of 355 nm and otherwise identical conditions as in
(A). Curves a0–c0 correspond to the spectra of BPT mixed with DNA
duplexes containing C, MeC, or dPER, respectively. (C) shows the dif-
ference between the emission spectra obtained at 346 and 355 nm
(a*=a0–a, b*=b0–b, and c*=c0–c).
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DISCUSSION
5-Methylcytosine (MeC) is among the most important en-
dogenous modiﬁcations found in the human genome. The
presence of MeC in gene promoter regions alters chromatin
structure, changes histone acetylation status (34,71) and
mediates DNA–protein interactions, allowing for the
control of gene expression (71–75). In mammalian cells,
MeC is produced by enzymatic methylation of the C5
position of cytosine by DNA C-5 cytosine
methyltransferases and is found predominantly at CG di-
nucleotides (76). About 80% of all CG sites are endogen-
ously methylated (72).
Healthy tissues have unique cytosine methylation
patterns that are carefully maintained upon DNA replica-
tion and cell division (76). However, abnormal cytosine
methylation has been observed in aging and in many
human diseases, including cancer (77). These epigenetic
changes may be caused by endogenous and exogenous
electrophiles that target CG dinucleotides in DNA
(78–80). For example, endogenously methylated CG di-
nucleotides found within the p53 tumor suppressor gene
are the sites of the major mutational ‘hotposts’ in smoking
induced lung cancer, suggesting that tobacco carcinogens
preferentially modify MeCG sequences (81,82). Previous
studies revealed that C-5 cytosine methylation increases
the reactivity of the N2-position of guanine in C:G base
pairs towards mitomycin C, mitoxantrone, esperamicins
A1 and C and PAH diol epoxides (22–25,83). In
contrast, the presence of MeC reduces the yields of O6-
alkylguanine adducts induced by alkyldiazonium ions
(28) and has little effect on the reactivity of guanine
bases towards formaldehyde (30) and aﬂatoxin B1-8,9-
epoxide (84).
The main goal of the present investigation was to
identify the chemical determinants responsible for
MeC-mediated effects on guanine adduct formation by car-
cinogenic PAH diolepoxides. In theory, MeC may inﬂu-
ence the reactivity of neighboring guanine bases towards
electrophiles by modifying DNA structure, mediating
pre-covalent binding of carcinogen to DNA, or by affect-
ing the local geometry and electronics of C:G pairs. To
distinguish between these possibilities, a series of
nucleobase mimics was developed featuring a range of
C-5 functionalized cytosines and related structural
analogs (Scheme 2), and their effects on the reactivity of
guanine introduced in the base paired position were
investigated.
We found that the introduction of hydrophobic C-5
alkyl groups on cytosine speciﬁcally facilitates the forma-
tion of N2-BPDE-dG adducts at its partner guanine
(Figures 2 and 3). Furthermore, the relative reactivity of
guanine towards BPDE increases as the size of the C-5
alkyl group at the base paired cytosine is increased in
the alkyl series (methyl-ethyl-propyl in Figure 2). A
smaller reactivity increase was observed for N-4
ethylcytosine:G base pairs which contain an alkyl group
at a different position of cytosine.
If C-5 methylation of cytosine activates the guanine
within MeC:G base pair towards BPDE adduction by an
electronic effect transmitted via G:C hydrogen bonds, the
introduction of electron withdrawing halogen substituents
at the same position should reduce the reactivity of base
paired guanine towards BPDE (27). Consistent with
previous studies involving mitomycin C (26,27,85), the
relative reactivity of guanine base paired to F-C decreases
by 20–40% relative to unsubstituted C:G base pair, likely
due to the electron withdrawing effects of the ﬂuoro sub-
stituent (Figure 4) (26,27,85). In contrast, N2-BPDE-dG
adduct formation was enhanced when Cl-C or Br-C were
placed opposite guanine in a DNA duplex, while the effect
Figure 8. Intercalation of the pseudo-diequatorial conformer of ()-anti-BPDE above (A) and below the plane of the MeC:G base pair (B) prior to
nucleophilic attack to form a covalent bond with the N2 position of guanine. The sequence that was used in the modeling study was an 11-mer
representing the experimental sequence used in the paper: 50-CCCGC[G]TCCGC-30/30-GGGC G[MeC]AGGCG-50 (where the MeC:G base pair is
indicated by the bracketed residues). Hydrogen bonded heavy atom donor–acceptor distances are indicated by white dotted lines, and the distances
between C10 of BPDE epoxide and the N2 exocyclic amine of the reactive guanine (i.e. d1 in Supplementary Table S5) are indicated by a yellow
dashed line. Note the formation of a hydrogen bond between the BPDE epoxide oxygen and the exocyclic amino group of the 50-ﬂanking guanine
(A), suggesting that the transition state of the reaction is stabilized by the DNA architecture.
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of I-C was dependent on diolepoxide stereochemistry
(Figure 4). This discrepancy may be explained by size dif-
ferences of the halogen substituents and by the ability of
Cl-C, Br-C and I-C, but not F-C, to serve as p-electron
donors. Collectively, these results indicate that electronic
effects alone cannot explain the effects of C-5 cytosine
methylation on reactivity of CG base pairs towards
BPDE and other electrophiles.
The most pronounced reactivity enhancement (up to
8-fold) was observed for structural analogs designed to
facilitate the intercalation of BPDE into DNA duplexs
(pyrrolo-C, phenyl pyrrolo-C and dPER) (Figures 5
and 6). BPDE intercalation between base pairs of the
DNA duplex is a required step for covalent adduct forma-
tion (86). Intercalative BPDE–DNA interactions also sig-
niﬁcantly accelerate the hydrolysis of BPDE to the
corresponding tetraols by stabilizing the transition state
for nucleophilic attack by water (7). Geacintov et al. (8)
have shown that BPDE prefers to intercalate within
oligodeoxynucleotide duplexes of poly(dG-MeC).
Furthermore, the ()-trans N2-BPDE-dG adducts
undergo a shift to an intercalated structure in the
presence of neighboring MeC (37).
Our non-line narrowing ﬂuorescence studies reveal that
trans-anti BPT (that was used as a hydrolytically stable
analog of BPDE) preferentially forms intercalative
complexes with DNA containing MeC and dPER as
compared to unmodiﬁed DNA duplex (Figure 7). These
results are supported by ﬂuorescence quenching experi-
ments conducted with benzo[a]pyrene-7S-trans-
7,8-dihydrodiol [(+)-BP78D] that was mixed with DNA
duplexes containing nucleobase analogs designed to
optimize p–p stacking interactions with BPDE (Pr-C,
Dft and dPER) (Supplementary Figure S7 and
Table S7). Examination of molecular models of BPDE–
DNA complexes (Figure 8) suggests that stacking inter-
actions between the pyrene ring system of BPDE and
5-methylcytosine place the epoxy ring of BPDE in a fa-
vorable orientation for nucleophilic attack by the amino
group of the base paired guanine, leading to increased N2-
BPDE-dG adduct yields. One exception is Pr-C:G base
pairs which exhibit a strong association with (+)-BP78D
(Supplementary Figure S7 and Table S7), but do not
display increased reactivity towards BPDE (Figure 5),
probably because the presence of C-5 propynyl substituent
places BPDE into the major groove of DNA.
In addition to its effects on reactivity of C:G base pairs
towards BPDE, MeC alters the diastereomeric composition
of the resulting DNA adducts. Four lesions are produced
upon nucleophilic attack of the exocyclic N2 position of
guanine by (±)-anti BPDE: (+)-trans-N2-BPDE-dG, ()-
trans-N2-BPDE-dG, (+)-cis-N2-BPDE-dG and ()-cis-N2-
BPDE-dG (Scheme 1). While (+)-trans-N2-BPDE-dG is
typically the major product formed (80–90% of total
adducts), minor stereoisomers may play an important
role in mutagenesis due to their distinct conformations
in double-stranded DNA (87–91). For example, nucleo-
tide excision repair of (+)-trans and ()-trans adducts is
less efﬁcient than that of (+)-cis and ()-cis adducts (87).
These differences can be explained by different adduct
conformations, with cis lesion assuming internal
(base displaced) conﬁgurations and trans adducts located
preferentially in the minor groove of DNA (15,17).
Although ﬂuorescence techniques in combination with
PAGE have been previously employed to demonstrate
DNA sequence effects on N2-BPDE-dG stereochemistry
(92), these methods do not provide quantitative informa-
tion for N2-BPDE-dG isomers generated at a given
guanine. The stable isotope labeling HPLC-ESI+-MS/
MS methodology developed in our laboratory (22)
makes it possible to quantify the stereoisomeric compos-
ition of N2-BPDE-dG adducts originating from speciﬁc
sites within the DNA duplex (Figure 1, pie charts in
Figures 2, 4–6). (±)-Anti-BPDE reaction with DNA
duplex containing standard G:C base pair yielded 89%
(+)-trans-N2-BPDE-dG, 5% ()-trans-N2-BPDE-dG, 4%
()-cis-N2-BPDE-dG and 2% (+)-cis-N2-BPDE-dG at the
target guanine (Figure 1A, pie charts in Figure 2A). When
the same duplex was treated with ()-anti-BPDE, 59%
()-trans-N2-BPDE-dG and 41% ()-cis-N2-BPDE-dG
was produced at the labeled guanine (pie chart in
Figure 2B).
The presence of alkyl or halogen substituents at the C-5
of cytosine did not change the stereochemical composition
of N2-BPDE-dG adducts produced at structurally
modiﬁed G:C base pairs (pie charts in Figures 2 and 4),
suggesting that these modiﬁcations do not alter the tran-
sition state geometry for N2-BPDE-dG adduct formation.
The introduction of base analogs with extended aromatic
systems further increased the relative yields of the (+)-
trans product (pie charts in Figure 5), probably by
stabilizing the precovalent complex of modiﬁed C:G
base pairs with the pseudo-diequatorial conformer I of
(+)-anti-BPDE (see above).
More pronounced differences in the stereochemistry of
N2-BPDE-dG adducts were observed for modiﬁed base
pairs unable to participate in standard Watson–Crick
hydrogen bonds, e.g. those containing Dft, the abasic
site and dPER (pie charts in Figure 6). Dft is a nonpolar
nucleoside mimic that lacks hydrogen bonding
functionalities, but preserves DNA structure via strong
stacking interactions with neighboring bases in the DNA
duplex (40). Our ﬂuorescence studies reveal an increased
association of (+)-BP78D (a hydrolytically stable analog
of ()-anti-BPDE) with Dft-containing DNA
(Supplementary Table S7). These results suggest that the
presence of Dft leads to the preferential intercalation of
()-anti-BPDE rather than (+)-anti-BPDE, thereby
decreasing the relative contributions of (+)-trans and
(+)-cis N2-BPDE-dG adducts at modiﬁed base pairs.
The presence of an abasic site opposite the target
guanine increases the contribution of cis N2-BPDE-dG
adducts, suggesting a preference for reaction through the
SN1-type mechanism (pie charts in Figure 6). We hypothe-
size that the geometry of the pre-covalent BPDE–DNA
complex at the G-AP site pair differs from that of the
standard G:C base pair due to a spacial void associated
with the introduction of an abasic site opposite target
guanine. The presence of dPER completely changes the
stereochemical outcome of the BPDE reaction with
guanine in the opposite strand (Figures 1D and 6),
4002 Nucleic Acids Research, 2011, Vol. 39, No. 9
producing large numbers of ()-trans adducts which are
rare at standard G:C base pairs (Figures 2 and 6).
Taken together, our results make it possible to propose
a likely model of how BPDE–DNA interactions are
modiﬁed by 5-methylcytosine, an important endogenous
base modiﬁcation that controls gene expression (75) and
governs the formation of smoking-induced lung cancer
mutational hotspots in the p53 tumor suppressor gene
(24). The majority of cytosine analogs considered in this
study displayed an increased reactivity towards BPDE,
which was associated with a facilitated physical complex
formation between BPDE and DNA. Density functional
calculations reveal that the electronic properties of the
modiﬁed C:G base pair are affected by the C-5 cytosine
substituent, but that these changes alone do not predict
reactivity (66). We conclude that C-5 methylation on
cytosine increases the yields of N2-BPDE-dG lesions at
the base paired guanine mostly by facilitating the forma-
tion of pre-covalent intercalative complexes with BPDE.
Additionally, the presence of MeC and unnatural
nucleobase analogs mediates the conformation of the
BPDE molecule in its complex with DNA, leading to
changes in stereochemistry of the resulting N2-BPDE-dG
adducts.
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